0648:HK:HK-CHINA RENJ (HKD)

COMMON STOCK | Other |

Last Closing

USD 0.38

Change

0.00 (0.00)%

Market Cap

USD 0.12B

Volume

N/A

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

China Wah Yan Healthcare Limited, an investment holding company, operates and manages a chain of medical centers for the diagnosis and treatment of tumors in the People's Republic of China. It operates through Health Management Business, Medical and Well Being Business, and Asset Management segments. The Health Management Business segment is involved in the operation of a chain of sports and healthcare clubhouses under the Megafit brand. The Medical and Well Being Business segment operates a chain of optical products and eye-care services retail shops under the Hong Kong Optical brand in Hong Kong; and a chain of medical centers specializing in the diagnosis and treatment of tumours, as well as leases medical equipment. The Asset Management segment invests in financial/fixed/distressed assets; and provides loan financing. The company also invests in properties; provides leisure fitness clubhouse services, and fitness training courses; and offers obstetric and gynecological services. The company was formerly known as China Renji Medical Group Limited and changed its name to China Wah Yan Healthcare Limited in June 2015. China Wah Yan Healthcare Limited was incorporated in 1989 and is based in Wanchai, Hong Kong.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-12-24 )

Largest Industry Peers for Other

Symbol Name Price(Change) Market Cap
1318:HK Mao Geping Cosmetics Co Ltd

-1.45 (-2.57%)

USD 26.31B
1863:HK China Longevity Group Company ..

N/A

USD 1.17B
8355:HK I-CONTROL

N/A

USD 0.39B
8343:HK HongGuang Lighting Holdings Co..

-0.02 (-3.28%)

USD 0.31B
0259-OL:HK YEEBO (INT'L H)

N/A

N/A
0400-OL:HK COGOBUY

+0.01 (+0.78%)

N/A
0406-OL:HK YAU LEE HOLD

-0.03 (-3.00%)

N/A
0294-OL:HK YANGTZEKIANG

N/A

N/A
0419-OL:HK JIUHAO HEALTH

N/A

N/A
0346-OL:HK YANCHANG PETRO

-0.01 (-3.64%)

N/A

ETFs Containing 0648:HK

N/A

Market Performance

  Market Performance vs. Industry/Classification (Other) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 12 Months  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) N/A N/A N/A N/A N/A
Risk Adjusted Return N/A N/A N/A N/A N/A
Market Capitalization 0.12B 20% F 23% F

Annual Financials (HKD)

Quarterly Financials (HKD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Underpriced on free cash flow basis

The stock is trading low compared to its peers on a price to free cash flow basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

High Gross Profit to Asset Ratio

This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.

Negative cashflow

The company had negative total cash flow in the most recent four quarters.